Literature DB >> 33768770

COVID-19-related risk of in-hospital death in Silesia, Poland.

Małgorzata Kowalska, Kamil Barański, Grzegorz Brożek, Angelina Kaleta-Pilarska, Jan E Zejda.   

Abstract

INTRODUCTION: The situation regarding COVID‑19 in Poland is rapidly evolving. Because of this, it is important to investigate COVID‑19 mortality and its predictors in one of the most densely populated regions of the country, Silesia Province.
OBJECTIVES: The goals of this study were to assess in‑hospital mortality due to COVID‑19 and the impact of sex, age, and coexisting diseases on the risk of death. PATIENTS AND METHODS: The data analysis was based on discharge reports of patients with COVID‑19 hospitalized between March and June 2020 in all hospitals in the region. Age, sex, hospital discharge status, and the presence of coexisting diseases were abstracted from the charts.
RESULTS: In a group of 2830 in‑patients with COVID‑19, 325 died during hospitalization. COVID‑19 deaths were associated with male sex (odds ratio [OR], 1.52; 95% CI, 1.17-1.96), older age (OR, 6.11; 95% CI, 4.5-8.31), and the presence of 3 or more coexisting diseases (OR, 4.78; 95% CI, 3.52-6.49). The most prevalent comorbidities were chronic cardiovascular and respiratory diseases.
CONCLUSIONS: The estimated in‑hospital fatality rate for COVID‑19 was 11.5%, which is lower than the average COVID‑19 fatality rate in other European countries. The risk of in‑hospital death was associated with sex, age, and the number of coexisting diseases, such as chronic cardiovascular and respiratory diseases.

Entities:  

Mesh:

Year:  2021        PMID: 33768770     DOI: 10.20452/pamw.15893

Source DB:  PubMed          Journal:  Pol Arch Intern Med        ISSN: 0032-3772


  4 in total

1.  Impact of COVID-19 Pandemic on Total Mortality in Poland.

Authors:  Kamil Barański; Grzegorz Brożek; Małgorzata Kowalska; Angelina Kaleta-Pilarska; Jan Eugeniusz Zejda
Journal:  Int J Environ Res Public Health       Date:  2021-04-20       Impact factor: 3.390

2.  Changes in Inflammatory Markers after Administration of Tocilizumab in COVID-19: A Single-Center Retrospective Study.

Authors:  Anna Olewicz-Gawlik; Barbara Ginter-Matuszewska; Mikołaj Kamiński; Agnieszka Adamek; Maciej Bura; Iwona Mozer-Lisewska; Arleta Kowala-Piaskowska
Journal:  J Clin Med       Date:  2021-12-25       Impact factor: 4.241

3.  Predictors of Mortality in Hemodialyzed Patients after SARS-CoV-2 Infection.

Authors:  Leszek Tylicki; Ewelina Puchalska-Reglińska; Piotr Tylicki; Aleksander Och; Karolina Polewska; Bogdan Biedunkiewicz; Aleksandra Parczewska; Krzysztof Szabat; Jacek Wolf; Alicja Dębska-Ślizień
Journal:  J Clin Med       Date:  2022-01-06       Impact factor: 4.241

4.  The Prevalence of Acute Respiratory Distress Syndrome (ARDS) and Outcomes in Hospitalized Patients with COVID-19-A Study Based on Data from the Polish National Hospital Register.

Authors:  Mariusz Gujski; Mateusz Jankowski; Daniel Rabczenko; Paweł Goryński; Grzegorz Juszczyk
Journal:  Viruses       Date:  2022-01-01       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.